AI assistant
CONMED Corp — Director's Dealing 2022
Mar 7, 2022
31971_dirs_2022-03-07_898735bc-2ed0-4654-a8eb-8ce17fa509fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-03-03
Reporting Person: KENNEDY JOHN JED (Group Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-03 | Common Stock | M | 5092 | $59.96 | Acquired | 14947 | Direct |
| 2022-03-03 | Common Stock | S | 5092 | $144.2521 | Disposed | 9855 | Direct |
| 2022-03-03 | Common Stock | M | 1790 | $78.76 | Acquired | 11645 | Direct |
| 2022-03-03 | Common Stock | S | 1790 | $144.3174 | Disposed | 9855 | Direct |
| 2022-03-03 | Common Stock | M | 832 | $97.69 | Acquired | 10687 | Direct |
| 2022-03-03 | Common Stock | S | 832 | $144.3304 | Disposed | 9855 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-03 | Options To Purchase Common Stock | $59.96 | M | 5092 | Disposed | 2028-03-01 | Common Stock (5092) | Direct |
| 2022-03-03 | Options To Purchase Common Stock | $78.76 | M | 1790 | Disposed | 2029-03-01 | Common Stock (1790) | Direct |
| 2022-03-03 | Options To Purchase Common Stock | $97.69 | M | 832 | Disposed | 2030-03-02 | Common Stock (832) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.25 to $144.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period